Astra Buying Bristol Makes No Sense, Fazeli Says

AstraZeneca's stock declined Monday following the announcement that the company was exploring an acquisition of Bristol Myers Squibb, which would create one of the world's largest pharmaceutical companies. Sam Fazeli of Bloomberg Intelligence stated that a takeover would not make sense.

Next story